Skip to main content

Willis appoints Plumeri successor

Dominic Casserley

Willis' board of directors has chosen Dominic Casserley, pictured, as the company's next chief executive.

Casserley, currently a senior partner at McKinsey & Company, will take the reins at the broker in January 2013.

Current CEO Joe Plumeri is ending tenure after 12 years at the helm and will serve as

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@postonline.co.uk or view our subscription options here: https://subscriptions.postonline.co.uk/subscribe

You are currently unable to copy this content. Please contact info@postonline.co.uk to find out more.

Sorry, our subscription options are not loading right now

Please try again later. Get in touch with our customer services team if this issue persists.

New to Insurance Post? View our subscription options

Register

Want to know what’s included in our free registration? Click here

Already have an account? Sign in here

Show password
Hide password

Q&A: James O’Hara, AbbeyAutoline

James O’Hara, a Chartered insurance broker and senior manager at AbbeyAutoline, reveals how he achieved one of the Chartered Insurance Institute’s highest global accolades after topping the performance charts in his Fellowship examinations.

Throwback Thursday: Biba’s talent help

Insurance Post’s Throwback Thursday steps back in time to September 1981 to remind you what was going on this week in insurance history when the British Insurance Brokers’ Association responded to demand from members for help with “personnel matters.”

McGill sold to EQT for $2bn

McGill and Partners and private equity firm EQT have entered into a definitive agreement in which the latter will acquire a majority stake in the former for $2bn (£1.5m).

Most read articles loading...

You need to sign in to use this feature. If you don’t have an Insurance Post account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here